Skip to content
10-Q

Quarterly Report

Dimension Therapeutics, Inc.

0001564590-17-021788

← back to feed
Filed
Nov 6, 2017 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2017 · Oct 30, 2017 25.37M sh
Capex Q3 2017 · Sep 30, 2017 $24K
Capex Q3 2017 · Sep 30, 2016 $6.44M
Cash And Equivalents Q3 2017 · Sep 30, 2017 $14.55M
Cash And Equivalents Q3 2017 · Dec 31, 2016 $30.23M
Cash And Equivalents Q3 2017 · Sep 30, 2016 $74.94M
Cash And Equivalents Q3 2017 · Dec 31, 2015 $127.05M
Stockholders Equity Q3 2017 · Sep 30, 2017 $20.35M
Stockholders Equity Q3 2017 · Dec 31, 2016 $59.94M
Current Liabilities Q3 2017 · Sep 30, 2017 $21.43M
Current Liabilities Q3 2017 · Dec 31, 2016 $20.64M
Total Liabilities Q3 2017 · Sep 30, 2017 $29.77M
Total Liabilities Q3 2017 · Dec 31, 2016 $33.92M
Current Assets Q3 2017 · Sep 30, 2017 $43.11M
Current Assets Q3 2017 · Dec 31, 2016 $85.32M
Total Assets Q3 2017 · Sep 30, 2017 $50.12M
Total Assets Q3 2017 · Dec 31, 2016 $93.87M
Sga Expense Q3 2017 · Sep 30, 2017 $5.32M
Sga Expense Q3 2017 · Sep 30, 2017 $11.36M
Sga Expense Q3 2017 · Sep 30, 2016 $3.31M
Sga Expense Q3 2017 · Sep 30, 2016 $9.48M
Rd Expense Q3 2017 · Sep 30, 2017 $16.13M
Rd Expense Q3 2017 · Sep 30, 2017 $43.94M
Rd Expense Q3 2017 · Sep 30, 2016 $13.8M
Rd Expense Q3 2017 · Sep 30, 2016 $33.84M
Net Income Q3 2017 · Sep 30, 2017 −$16.95M
Net Income Q3 2017 · Sep 30, 2017 −$42.75M
Net Income Q3 2017 · Sep 30, 2016 −$14.37M
Net Income Q3 2017 · Sep 30, 2016 −$35.98M
Operating Income Q3 2017 · Sep 30, 2017 −$16.97M
Operating Income Q3 2017 · Sep 30, 2017 −$42.83M
Operating Income Q3 2017 · Sep 30, 2016 −$14.34M
Operating Income Q3 2017 · Sep 30, 2016 −$35.98M
Revenue Q3 2017 · Sep 30, 2017 $4.48M
Revenue Q3 2017 · Sep 30, 2017 $12.47M
Revenue Q3 2017 · Sep 30, 2016 $2.76M
Revenue Q3 2017 · Sep 30, 2016 $7.34M